Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01080157 · ClinicalTrials.gov registry record
Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes
A clinical trial of Diabetes, sponsored by VeraLight.
- Completed
- Registry status
- 509
- Enrollment target
- 12
- Study locations
NCT01080157: Completed study of Diabetes, sponsored by VeraLight.
NCT01080157 is a study of Diabetes that has completed, run by VeraLight. The registered enrollment target is 509 participants, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (83% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01080157, a study of Diabetes, has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 509 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOUT DS is being developed to help doctors measure these substances in skin and possibly help doctors diagnose diabetes.
Primary Outcome
The relative true positive and relative true negative fractions between the SCOUT DS and FPG tests for detecting abnormal glucose tolerance (2 hr OGTT value ≥ 140 mg/dL)
Conditions Studied
Interventions
- DEVICE SCOUT DS measurement
Study Locations (12)
Texas
- Juno Research, LLC - Houston
- Dynamed Clinical Research, LP - Houston
- Radiant Research, Inc. - San Antonio - San Antonio
Illinois
- Radiant Research, Inc. - Chicago - Chicago
- Accelovance - Peoria, IL - Peoria
Alabama
- Accelovance - Huntsville - Huntsville
California
- Accelovance - San Diego, CA - San Diego
Kansas
- Radiant Research, Inc. - Kansas City - Kansas City
Maryland
- Accelovance - Rockville, MD - Rockville
Minnesota
- Radiant Research, Inc. - Minneapolis - Minneapolis
New Mexico
- Lovelace Scientific Resources, Inc. - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-12 |
What the finished NCT01080157 record still lists
NCT01080157 is an observational study that tracks outcomes without assigning an intervention. The registered 509 participants enrollment target is mid-sized for trials with a published cap, below the 3,027-participant average among 338 other Diabetes trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which SCOUT DS measurement is the first listed.
NCT01080157 lists 12 locations in 9 states (Texas, Illinois, Alabama).
Frequently Asked Questions
What is clinical trial NCT01080157 about?
NCT01080157 is a clinical study titled "Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes". The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOU...
What is the current status of trial NCT01080157?
This trial is currently completed. The enrollment target is 509 participants. The study started on 2010-03. Estimated completion is 2010-12.
What conditions does trial NCT01080157 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT01080157?
The interventions under investigation include: SCOUT DS measurement (DEVICE).
Who is sponsoring clinical trial NCT01080157?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01080157 being conducted?
This trial has 12 study locations across Alabama, California, Illinois, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01080157's enrollment target sits among peer trials
509 71st of 338 higher than 268 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia